Completed PHASE1 INTERVENTIONAL NCT00001777

Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)

A Controlled, Randomized, Double-Blind Trial of Sertraline in Patients With Frontal Lobe Dementia (FLD)

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Conditions Dementia

Interventions Sertraline

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Dec 31, 1997 Completion: May 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Dementia, this trial is completed. The trial is conducted by National Institute of Neurological Disorders and Stroke (NINDS) and has accumulated 5 data snapshots since 1997. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Dec 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Neurological Disorders and Stroke (NINDS)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States